143 related articles for article (PubMed ID: 11465907)
1. Update: syringe exchange programs--United States, 1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):384-7. PubMed ID: 11465907
[TBL] [Abstract][Full Text] [Related]
2. Update: syringe exchange programs--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(27):673-6. PubMed ID: 16015218
[TBL] [Abstract][Full Text] [Related]
3. Update: syringe exchange programs--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(31):652-5. PubMed ID: 9716397
[TBL] [Abstract][Full Text] [Related]
4. Syringe exchange programs--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(44):1164-7. PubMed ID: 17989646
[TBL] [Abstract][Full Text] [Related]
5. Update: syringe-exchange programs--United States, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jun; 46(24):565-8. PubMed ID: 9221326
[TBL] [Abstract][Full Text] [Related]
6. Syringe exchange programs --- United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
[TBL] [Abstract][Full Text] [Related]
7. Syringe exchange programs--United States, 1994-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Sep; 44(37):684-5, 691. PubMed ID: 7666847
[TBL] [Abstract][Full Text] [Related]
8. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
[TBL] [Abstract][Full Text] [Related]
9. Doing harm reduction better: syringe exchange in the United States.
Des Jarlais DC; McKnight C; Goldblatt C; Purchase D
Addiction; 2009 Sep; 104(9):1441-6. PubMed ID: 19215605
[TBL] [Abstract][Full Text] [Related]
10. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
11. Syringe exchange in the United States: 1995 update.
HIV Capsule Rep; 1996 Feb; (No 1):1-3. PubMed ID: 11367404
[TBL] [Abstract][Full Text] [Related]
12. Strategies to optimize the impact of needle exchange programs.
Rich JD; Strong LL; Mehrotra M; Macalino G
AIDS Read; 2000 Jul; 10(7):421-9. PubMed ID: 10932846
[TBL] [Abstract][Full Text] [Related]
13. Secondary syringe exchange among users of 23 California syringe exchange programs.
Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
[TBL] [Abstract][Full Text] [Related]
14. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
[TBL] [Abstract][Full Text] [Related]
16. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
[TBL] [Abstract][Full Text] [Related]
17. Strategies to improve access to sterile syringes for injection drug users.
Rich JD; Wolf FA; Macalino G
AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
[TBL] [Abstract][Full Text] [Related]
18. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
19. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
20. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
